HECHT BETH (See Remarks) sold 1.3% of their position (16.67K shares) of XERIS BIOPHARMA HOLDINGS, INC. on the open market
Open‑market sale worth $104.1K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 3/4/2026ACC: 0001652410-26-000006
Officer· See Remarks
Since Oct 2021
-16.67K
Net shares
Net seller
$104.1K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
16.67K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−16.57K
Price / share
$6.24
Trade value
$103.38K
% of position
1.3%
3/2/2026
1.24M→1.23M
Common Stock
Direct
Shares
−100.00
Price / share
$7.06
Trade value
$706.00
% of position
0.0%
3/2/2026
1.23M→1.23M
Total
Net shares
−16.67K
Net value
-$104.09K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/2/2026 | S · Sale | −16.57K | $6.24 | $103.38K | 1.3% | 1.24M | 1.23M |
| Common Stock Direct | 3/2/2026 | S · Sale | −100.00 | $7.06 | $706.00 | 0.0% | 1.23M | 1.23M |
| Total | −16.67K | -$104.09K | ||||||
Derivative Transactions0
No derivative transactions reported